Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study (Q38964573)

8 September 2017

title

Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study (English)

1 reference

8 September 2017

Silvia Francisci

4

0 references

Paolo Baili

Paolo Baili

5

0 references

Roberta De Angelis

Roberta De Angelis

1

0 references

Milena Sant

Milena Sant

2

0 references

Magdalena Bielska-Lasota

Magdalena Bielska-Lasota

11

0 references

Michel P. Coleman

Michel P Coleman

3

0 references

Hermann Brenner

Hermann Brenner

9

0 references

Eva Ardanaz

10

Eva Ardanaz

1 reference

8 September 2017

0 references

Daniela Pierannunzio

6

1 reference

8 September 2017

Annalisa Trama

7

1 reference

8 September 2017

Otto Visser

8

1 reference

8 September 2017

Gerda Engholm

12

1 reference

8 September 2017

Alice Nennecke

13

1 reference

8 September 2017

Sabine Siesling

14

1 reference

8 September 2017

Franco Berrino

15

1 reference

8 September 2017

Riccardo Capocaccia

16

1 reference

8 September 2017

EUROCARE-5 Working Group

17

1 reference

8 September 2017

publication date

5 December 2013

1 reference

Lancet Oncology Commission

8 September 2017

published in

1 reference

8 September 2017

volume

15

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

23-34

1 reference

Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Survival of patients diagnosed with cancer in the Nordic countries up to 1999-2003 followed to the end of 2006. A critical overview of the results.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Euromelanoma: a dermatology-led European campaign against nonmelanoma skin cancer and cutaneous melanoma. Past, present and future.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

The National Awareness and Early Diagnosis Initiative in England: assembling the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Management of ovarian cancer: referral to a multidisciplinary team matters

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Impact of volume and specialization for cancer surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Multiple tumours in survival estimates

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370 000 cancer patients in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Standard cancer patient population for age standardising survival ratios

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Evidence against the proposition that "UK cancer survival statistics are misleading": simulation study with National Cancer Registry data

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Has there been progress in cancer care in Croatia? Assessing outcomes in a partially complete mortality follow-up setting

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Epidemiological research labelled as a violation of privacy: the case of Estonia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Explaining gastric cancer survival differences among European countries

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Breast cancer mortality patterns and time trends in 10 new EU member states: mortality declining in young women, but still increasing in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

The size of the prize for earlier diagnosis of cancer in England

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Breast cancer survival in England, Norway and Sweden: a population-based comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Treatment and survival in breast cancer in the Eastern Region of England

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

A comparison of prostate cancer survival in England, Norway and Sweden: A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Non-Hodgkin lymphoma: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Results of radical surgery for rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

A Systematic Overview of Radiation Therapy Effects in Rectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Progress in the multidisciplinary treatment of gastrointestinal cancer and the impact on clinical practice: perioperative management of rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970546-1

7 January 2021

10.1016/S1470-2045(13)70546-1

Identifiers

DOI

1 reference

8 September 2017

1 reference